Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.

Morning infusions were also associated with numerically improved OS, but these findings did not reach statistical significance (log-rank p=0.15) ( figure 1B ).

also in 111,027 other papers